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SYNOPSIS 
Adenosine 5’ triphosphate (ATP) is a molecule central to life for its role as the 
cellular energy currency, and a purine nucleotide which serves as a building block of RNA. 
Thus, on the backdrop of an indispensible intracellular role of ATP, its identification as an 
extracellular signaling molecule in early 1970s came as a surprise. A novel doctrine, termed 
as ‘purinergic signaling’, was thus put forth. By definition, purinergic signaling consists of 
the signaling events triggered by binding of extracellular ATP- a purine nucleotide, and its 
breakdown products (viz., ADP, AMP, and adenosine) to their cognate receptors, which in 
turn are termed as ‘purinergic receptors’.  
Based on their ligand affinity, purinergic receptors are classified into two groups- P1 
and P2 receptors. P2 receptors are further subclassified as P2X and P2Y receptors. Till date, 
four P1 receptors (viz. A1, A2a, A2b, and A3), seven P2X receptors (P2X1-7), and eight 
P2Y receptors (P2Y1, P2Y2, P2Y4, P2Y6, P2Y11, P2Y12, P2Y13, and P2Y14) have been 
cloned and characterized. Conceptually, the first step of purinergic signaling is the release of 
ATP from an intact cell on encountering a stimulant or a modulator. The main mechanisms 
of such cellular ATP release include vesicular exocytosis and the release through conductive 
channels. ATP thus released, binds to its cognate receptors (i.e. P2X receptors, and certain 
P2Y receptors) and triggers the ‘purinergic signaling’ pathway that modulates the cellular 
response. In addition to purinergic receptors, cells also express ATP degrading enzymes on 
their surface, which break ATP down into ADP, AMP, and adenosine. ADP and adenosine, 
in turn, bind to their cognate receptors (certain P2Y receptors, and P1 receptors respectively) 
and further contribute to shaping the cellular response to a given cue. Thus, purinergic 
signaling is a highly dynamic process with pleiotropic downstream effects.  
First demonstrated in the context of neurotransmission, the phenomenon of purinergic 
signaling is now widely recognized and has been shown to play a role in regulating 
functional responses of cells of diverse origins, immune cells being one of them. Purinergic 
signaling in lymphocytes- an important subset of immune cells- is a common thread for the 
present research exercise, wherein we have addressed two sets of questions, one of academic 
curiosity and the other of clinical interest. In the former and the major part, we have 
examined whether purinergic signaling plays a role in functional aspects of ‘gamma delta 
(γδ) T cells’, which represent a unique subset of lymphocytes. Whereas, the latter part 
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elaborates on the already identified involvement of purinergic signaling in T cell stimulatory 
action of ‘hypertonic saline (HS)’, which is used to treat trauma patients.  
The thesis, thus, is divided into five parts- the ‘Introduction’, ‘Aims and Scope of the 
study’, ‘Chapter 1’, ‘Chapter 2’, and ‘Summary of the work’.  
Understanding the questions posed in the present context, strategy designed to answer 
them, and eventually the experimental results answering these questions invoke basic 
knowledge of purinergic signaling, which has been attempted to be conferred through the 
‘Introduction’ section. The discovery of purinergic signaling, its central theme, and 
individual molecular players involved in this signaling pathway are highlighted here. From 
the viewpoint of the present research endeavor, salient findings from the current literature- 
about the involvement of purinergic signaling in the functional activities of various subsets of 
immune cells- are reviewed towards the end of this section.   
The ‘Introduction’ is followed by definition of the objectives for the present exercise, 
which are enlisted under ‘Aims and scope of the study’. Here, a brief overview of the 
background data that led us towards these objectives precedes the actual list of questions 
which we have approached.   
Purinergic signaling has been shown to play a role in the activation of ‘conventional 
αβ T’ cells. So we asked whether a similar purinergic signaling pathway also operates in 
unconventional γδ T cells. Thus, ‘Chapter 1’ is dedicated to answering the first set of 
questions about the role of purinergic signaling in γδ T cell activation. The chapter starts off 
by introducing γδ T cells. The topics such as discovery of γδ T cells, ontology, development, 
diversity, and distribution of these cells, and most importantly- their antigenic specificity and 
response are reviewed herein. The details of the experimental procedures employed to 
answer the defined objectives follow this introduction. We have carried out our experiments 
on γδ T cells in human circulation. For in vitro stimulation, we have used anti-CD3 + anti-
CD28-coated beads (beads) or isopentenyl pyrophosphate (IPP), a γδ T cell specific 
stimulant. We observed that, circulating human γδ T cells rapidly release ATP on stimulation 
with beads or IPP. Pannexin-1 and connexin hemichannels, as well as vesicular exocytosis 
contribute to the ATP release. Real time RT-PCR data revealed that γδ T cells predominantly 
express purinergic receptors A2a, P2X1, P2X4, P2X7, and P2Y11. Of these, the inhibition of 
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P2X4 receptors downregulated cytokine expression by γδ T cells post- in vitro stimulation, 
and also inhibited cytotoxic activity of γδ T cells towards Daudi cells. Selective translocation 
of P2X4 receptors to the immunological synapse was seen to be the underlying mechanism 
for these effects. Collectively, these data suggested that autocrine/paracrine purinergic 
signaling through P2X4 receptors indeed plays an important role in the functional aspects of 
circulating human γδ T cells. The experimental results are compiled in ‘Chapter 1’; which 
concludes with the ‘Discussion’ on the mentioned findings, and possible in vivo applications.  
 ‘Chapter 2’ deals with the role of purinergic signaling in HS resuscitation. In addition 
to restoring the hemodynamic parameters, fluid replacement with small volumes of 
concentrated NaCl solution (HS) has been reported to reverse the suppression of T cells 
commonly found in the trauma subjects. Through an in vitro study using Jurkat cells as a 
model for primary human T cells, it has been shown earlier that, on HS exposure T cells 
release ATP- which binds to P2X7 receptors and promotes calcium influx. HS treatment also 
elicits phosphorylation of p38; and put together, Ca2+ influx and phosphorylated p38 
synergize with TCR-induced stimulation resulting in the enhancement of transcriptional 
upregulation of IL-2. However, the mechanism of release of ATP on HS treatment and the 
possible involvement of P2X1 and P2X4 receptors expressed by T cells had not been 
addressed in this study. These very questions thus formed the objectives of the second part of 
present work. Experiments aimed to answer these questions showed that on HS treatment, 
Jurkat cells release ATP through pannexin-1 hemichannels. The released ATP binds to 
purinergic receptors P2X1, P2X4, and P2X7. This in turn triggers the downstream signaling 
cascade leading to phosphorylation of p38 and upregulation of IL-2 transcription, hence 
augmenting the T cell function. An overview of HS resuscitation, experimental protocols and 
results, and the discussion on the pathophysiological relevance of these findings comprise 
‘Chapter 2’.  
 Hence, we have found the answers to the questions we began with. The results are 
listed in a point-wise manner under the ‘Summary of the work’. Taken together, our data 
shows that: 
(i) Purinergic signaling does play a role in the functional aspects of circulating human γδ 
T cells. The release of ATP by γδ T cells post-stimulation, and autocrine/paracrine 
signaling through P2X4 receptors are the main components in this context.  
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(ii) ATP release through pannexin-1 hemichannels, and autocrine/paracrine signaling 
through P2X1, P2X4, and P2X7 receptors underlie the mechanism of action of HS. 
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